查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379033

2023-2028 年按应用（糖尿病、肥胖、心血管疾病、中枢神经系统疾病、呼吸系统疾病、戒烟等）、最终用途（患者、提供者、付款人、雇主等）和地区分類的数位治疗市场报告

Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球数位治疗市场规模达到50亿美元。展望未来， IMARC Group预计到2028年市场规模将达到150亿美元，2022-2028年复合年增长率（CAGR）为20.1%。对数位行为监测治疗的需求不断增长、慢性病盛行率不断上升以及大众对个人健康和健身意识的不断提高是推动市场的关键因素之一。

智慧型手机和平板电脑使用量的增加推动市场成长

对智慧型手机和平板电脑的日益依赖，加上不同的医疗保健应用程序，正在推动数位治疗市场的成长。智慧型手机和基于平板电脑的医疗保健应用程式具有降低用药错误率、促进预防性护理和更准确的人员配置等众多优势。个人科技设备在医疗保健领域的使用不断增加，刺激了对数位疗法 (DTx) 治疗的需求。 DTx 正在增强患者获得治疗的安全性和有效性，以不同语言呈现讯息，提供有关疾病和治疗的相关信息，并扩大医生护理患者的能力。此外，它是一种先进的护理服务模式，可以在家中轻鬆实施，并消除与传统疗法相关的任何耻辱。

数位治疗市场趋势：

报告涵盖了市场结构、主要参与者的市场份额、参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。市场结构适度分散，有大量全球和区域参与者。此外，由于研发（R＆D）创新和併购（M＆A）数量的增加，该市场的竞争环境正在加剧。由于市场结构分散、产品差异化和转换成本较低，数位治疗行业的新进入者数量适中。此外，行动医疗开发商数量的不断增加也加剧了新进入者的巨大威胁。然而，先进技术的专利要求和高成本以及严格的监管程序减少了新进入者的威胁。

什么是数位治疗？

数位疗法 (DTx) 是一种由高品质软体程式驱动的实证治疗介入措施，用于预防、管理或治疗医学病症或疾病。它是软体即医疗设备 (SaMD) 的一种形式，依靠软体介入来改变患者的行为并帮助治疗他们的病情。 DTx 是一类快速且新兴的疗法，利用软体独立治疗疾病或优化治疗。它有助于预防和管理多种疾病和病症，如2 型糖尿病、充血性心臟衰竭、肥胖、阿兹海默症、失智症、气喘、药物滥用、注意力不足过动症(ADHD)、高血压、焦虑、忧郁、和其他几个。 DTx 还有助于提高患者用药依从性，并支持医疗保健专业人员 (HCP) 以数位方式管理患者和业务。

COVID-19 影响：

COVID-19大流行的到来可谓医疗保健产业的分水岭。它极大地改变了医疗保健提供的方式，同时暴露了世界各国政府在充分应对全球医疗保健紧急情况方面缺乏准备。第一线卫生工作者参与管理 COVID-19 患者，但患有其他健康问题的患者，尤其是慢性健康问题的患者，由于推迟或避免去诊所就诊，因此遇到了困难。此外，由于患有合併症（尤其是肥胖、心臟併发症和糖尿病）的患者中的 COVID-19 结局比没有合併症的患者更差，因此要求这些患者额外保持警惕。这场大流行也带来了相当一部分精神健康障碍，包括忧郁、焦虑和戒断，由于缺乏面对面的就诊，这些疾病的管理是一个挑战。这些相互关联的事件促使医疗保健提供者寻求数位健康解决方案来应对健康危机。在 COVID-19 爆发期间，数位医疗技术的采用出现了积极的趋势，提高了医疗保健营运和服务提供的效率和有效性。疫情发生后，DTx应用在各领域的采用加速了数倍。此外，COVID-19 大流行透过改变患者参与度和整合整个医疗保健领域的资料，增加了虚拟和家庭护理技术的采用。

数位治疗市场趋势：

目前，2 型糖尿病患者对 DTx 的需求不断增加，以控制疾病并使他们能够使用支援物联网 (IoT) 的胰岛素帮浦和其他健康监测系统。再加上对数位行为监测治疗的需求不断增长，以确保药物依从性和健康生活方式的改变，这是支持市场成长的关键因素之一。此外，与传统治疗相比，越来越多地使用 DTx 来减少更多后续检查和復发的需要，这提供了良好的市场前景。此外，心臟病、中风、癌症、肥胖和关节炎等慢性疾病的盛行率也在增加。再加上大众对个人健康和健身意识的不断提高，正在推动市场的成长。此外，对 DTx 的需求不断增长，以帮助医生管理患者对医疗方案的依从性，并建立一个综合的健康生态系统，使资料能够在付款人、提供者和药房等不同利益相关者之间无缝传输，这正在推动市场的成长。

本报告回答的关键问题

  • 2022 年全球数位治疗市场规模有多大？
  • 2023-2028年全球数位治疗市场的预期成长率是多少？
  • 推动全球数位治疗市场的关键因素是什么？
  • COVID-19 对全球数位治疗市场有何影响？
  • 基于应用的全球数位治疗市场的细分情况如何？
  • 根据最终用途，全球数位治疗市场的细分情况如何？
  • 全球数位治疗市场的关键区域有哪些？
  • 谁是全球数位治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球数位治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按应用分類的市场区隔

  • 糖尿病
    • 市场走向
    • 市场预测
  • 肥胖
    • 市场走向
    • 市场预测
  • CVD
    • 市场走向
    • 市场预测
  • 中枢神经系统疾病
    • 市场走向
    • 市场预测
  • 呼吸疾病
    • 市场走向
    • 市场预测
  • 戒烟
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：依最终用途分類的市场区隔

  • 患者
    • 市场走向
    • 市场预测
  • 供应商
    • 市场走向
    • 市场预测
  • 付款人
    • 市场走向
    • 市场预测
  • 雇主
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 2Morrow Inc.
    • Canary Health Inc.
    • Click Therapeutics Inc.
    • Mango Health Inc. (TrialCard Incorporated)
    • Noom Health Inc.
    • Omada Health Inc.
    • Pear Therapeutics, Inc.
    • Propeller Health (ResMed)
    • Teladoc Health Inc.
    • Voluntis Inc.
    • WellDoc Inc.
Product Code: SR112023A3889

Abstract

The global digital therapeutics market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2028, exhibiting a growth rate (CAGR) of 20.1% during 2022-2028. The growing demand for digital behavior-monitoring treatment, increasing prevalence of chronic diseases, and rising awareness among the masses about personal health and fitness represent one of the key factors driving the market.

Increasing Usage of Smartphones and Tablets Propelling Market Growth

The rising reliance on smartphones and tablets, coupled with different healthcare apps, is propelling the growth of the digital therapeutics market. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. The increasing utilization of personal technological devices in healthcare is catalyzing the demand for digital therapeutics (DTx) treatments. DTx is enhancing patient access to the safety and effectiveness of treatments, presenting information in different languages, providing relevant information about diseases and treatments, and expanding the ability of physicians to care for patients. Furthermore, it is an advanced mode of care delivery, which can be easily implemented at home and eliminates any stigma associated with traditional therapies.

Digital Therapeutics Market Trends:

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of a large number of global and regional players. Moreover, the competitive environment in this market is intensifying due to the increasing number of research and development (R&D) innovations and mergers and acquisitions (M&A). The volume of new entrants is moderate in the digital therapeutics industry due to the fragmented market structure and low product differentiation and switching cost. In addition, the growing number of mhealth developers is contributing to the high threat of new entrants. However, the requirement of patents and high costs of advanced technologies along with stringent regulatory procedures, decreases the threat from new entrants.

What are Digital Therapeutics?

Digital therapeutics (DTx) is an evidence-based therapeutic intervention driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. It is a form of a software-as-a-medical device (SaMD) that relies on software interventions to bring about behavioral changes in patients and help treat their conditions. DTx is a fast-emerging class of therapies that utilizes software to treat disease as a standalone or for treatment optimization. It assists in preventing and managing a wide variety of diseases and conditions, such as type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, and several others. DTx also aids in improving patient medication adherence and supporting healthcare professionals (HCPs) to manage their patients and businesses digitally.

COVID-19 Impact:

The arrival of the COVID-19 pandemic can be described as a watershed moment for the healthcare industry. It changed the manner of healthcare delivery dramatically while exposing the lack of preparedness on the part of governments worldwide to adequately tackle a global healthcare emergency. Frontline health workers were involved in managing COVID-19 patients, but patients with other health conditions, especially chronic health conditions, experienced difficulties as their in-clinic visits were postponed or avoided. Moreover, as the outcomes of COVID-19 among patients with comorbidities, especially obesity, heart complications, and diabetes, were worse than those without, these patients were asked to be additionally vigilant. The pandemic also brought a fair share of mental health disorders, including depression, anxiety, and withdrawals, and their management was a challenge due to the lack of face-to-face visits. These interconnected events have made healthcare providers look out for digital health solutions to tackle health crisis. There was a positive trend observed during the COVID-19 outbreak in relation to the adoption of digital health technologies, which increased the efficiency and effectiveness of healthcare operations and service delivery. After the pandemic started, the adoption of DTx applications in various fields accelerated many folds. Additionally, the COVID-19 pandemic increased the adoption of virtual and home care technologies by transforming patient engagement and integrating data across the healthcare landscape.

Digital Therapeutics Market Trends:

At present, there is a rise in the demand for DTx among type 2 diabetes patients to manage the disease and enable them to use the internet of things (IoT)-enabled insulin pumps and other health monitoring systems. This, along with the increasing demand for digital behavior-monitoring treatment to ensure medication adherence and healthy lifestyle changes, represents one of the key factors supporting the growth of the market. In addition, the growing utilization of DTx to reduce the need for more follow-up checkups and relapses compared to traditional treatments is offering a favorable market outlook. Moreover, there is an increase in the prevalence of chronic diseases, such as heart disease, stroke, cancer, obesity, and arthritis. This, coupled with the rising awareness among the masses about personal health and fitness, is propelling the growth of the market. Additionally, the escalating demand for DTx to help doctors manage patient adherence to medical regimens and build an integrated health ecosystem that can enable the seamless transfer of data between different stakeholders, such as payers, providers, and pharmacies, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application and end use.

Application Insights:

Diabetes

Obesity

CVD

CNS Disease

Respiratory Diseases

Smoking Cessation

Others

The report has provided a detailed breakup and analysis of the digital therapeutics market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. According to the report, diabetes represented the largest segment due to the rising prevalence of diabetes, along with the high risk of associated conditions, such as cardiac arrests, kidney failure, and blindness, in diabetic patients. Moreover, the growing integration of DTx with numerous medical devices, such as insulin pumps, glucose blood meters, and wearable gadgets, is positively influencing the market.

End Use Insights:

Patients

Providers

Payers

Employers

Others

A detailed breakup and analysis of the digital therapeutics market based on the end use has also been provided in the report. This includes patients, providers, payers, employers, and others. According to the report, patients accounted for the largest market share due to the rising adoption of DTx among patients for numerous associated benefits pertaining to elective health management at an affordable cost. In addition, the increasing consumer inclination towards patient management systems for improving retention and compliance with post hospitalization follow-up visits is catalyzing the demand for DTx.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for digital therapeutics. Some of the factors driving the North America digital therapeutics market included the growing geriatric population, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), rising awareness about the benefits of DTx, etc. In addition, the growing utilization of DTx as a standalone therapy or in conjunction with medications, devices, and other therapies to optimize patient care and healthcare outcomes is offering a favorable market outlook.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global digital therapeutics market. Some of the companies covered in the report include:

2Morrow Inc.

Canary Health Inc.

Click Therapeutics Inc.

Mango Health Inc. (TrialCard Incorporated)

Noom Health Inc.

Omada Health Inc.

Pear Therapeutics, Inc.

Propeller Health (ResMed)

Teladoc Health Inc.

Voluntis Inc.

WellDoc Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global digital therapeutics market in 2022?
  • 2. What is the expected growth rate of the global digital therapeutics market during 2023-2028?
  • 3. What are the key factors driving the global digital therapeutics market?
  • 4. What has been the impact of COVID-19 on the global digital therapeutics market?
  • 5. What is the breakup of the global digital therapeutics market based on the application?
  • 6. What is the breakup of the global digital therapeutics market based on the end use?
  • 7. What are the key regions in the global digital therapeutics market?
  • 8. Who are the key players/companies in the global digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Obesity
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CVD
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CNS Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Smoking Cessation
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Providers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Payers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Employers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 2Morrow Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Canary Health Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Click Therapeutics Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Mango Health Inc. (TrialCard Incorporated)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Noom Health Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Omada Health Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Pear Therapeutics, Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Propeller Health (ResMed)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Teladoc Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Voluntis Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 WellDoc Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
  • Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
  • Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Digital Therapeutics Market: Competitive Structure
  • Table 6: Global: Digital Therapeutics Market: Key Players